FATE
Fate Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD2.22
-0.35 (-13.62%)
Rating:C
Company Profile
CEO
Bahram Valamehr
IPO Date
2013-10-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$2.51
Prev. Close
$2.57
Day Low
$2.19
Day High
$2.57
52W Low
$0.91
52W High
$2.88
Market Cap
$0.26B
Volume
7.47M